ArticleExperimental hematology & oncology2015

CDKN1A and FANCD2 are potential oncotargets in Burkitt lymphoma and multiple myeloma.

Seong-Su Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.